We identified truncal VHL loss in all the patients, and although this is a major driver of the difference in metabolism between tumour and normal tissue, it is unlikely to contribute to the intratumoral metabolic heterogeneity detected using HP 13C-MRI. The gene discussed is VHL; the disease is neoplasm.